| 今开：3.25 | 昨收：3.25 |
| 最高：3.26 | 最低：2.93 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.56554142E8 |
Kodiak Sciences(KOD)05-16 04:15
$Kodiak Sciences(KOD)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-060455 Act: 34 Size: 254 KB 网页链接查看全文
Kodiak Sciences(KOD)07-02 06:25
$Kodiak Sciences(KOD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-018658 Size: 5 KB 网页链接查看全文
Kodiak Sciences(KOD)07-02 06:25
$Kodiak Sciences(KOD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-018663 Size: 5 KB 网页链接查看全文
Kodiak Sciences(KOD)07-03 04:55
$Kodiak Sciences(KOD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-080612 Size: 22 KB 网页链接查看全文
Kodiak Sciences(KOD)06-07 04:15
$Kodiak Sciences(KOD)$ 8-K Current report, item 5.07 Accession Number: 0001193125-24-156056 Act: 34 Size: 148 KB 网页链接查看全文
Kodiak Sciences(KOD)06-14 04:45
$Kodiak Sciences(KOD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-016682 Size: 9 KB 网页链接查看全文
Kodiak Sciences(KOD)07-02 06:25
$Kodiak Sciences(KOD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-018655 Size: 5 KB 网页链接查看全文
Kodiak Sciences(KOD)07-02 06:25
$Kodiak Sciences(KOD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-018661 Size: 5 KB 网页链接查看全文
Kodiak Sciences(KOD)05-16 04:25
$Kodiak Sciences(KOD)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-060483 Act: 34 Size: 4 MB 网页链接查看全文
Kodiak Sciences(KOD)06-19 17:26
$Kodiak Sciences(KOD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-017449 Size: 11 KB 网页链接查看全文
网络异常请稍后再试2023-07-26 12:47
$Kodiak Sciences(KOD)$ 眼病对于副作用的容忍度是非常非常小的。
KSI-301是基于ABC平台开发的一款抗VEGF药物，旨在延长药物在眼部组织的作用时间，从而改善视网膜血管疾病患者的预后，并为糖尿病眼病患者提供早期治疗和预防视力丧失的方案。尽管KSI-301显示出了治疗潜力，但Kodiak还是决定终...查看全文
SeekingBiotech2023-07-24 21:52
$Kodiak Sciences(KOD)$
KOD Announces Topline Results from its Phase 3 Studies of Tarcocimab Tedromer in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema.
GLEAM and GLIMMER studies did not meet their primary efficacy endpoints. 又一个错失终点nAM...查看全文
不入流资讯2023-07-24 19:50
$Kodiak Sciences(KOD)$ Kodiak Sciences plummets 47% after scraping development of eye disorder drug查看全文
产业链观察2023-07-24 18:08
#药闻简讯# $Kodiak Sciences(KOD)$ 公布 Tarcocimab Tedromer 治疗新生血管性老年黄斑变性和糖尿病性黄斑水肿的 3 期研究的初步结果。
GLEAM和GLIMMER研究未达到主要疗效终点#临床研究失败#查看全文
产业链观察2022-08-08 19:55
药闻▶2022年8月8日，$Kodiak Sciences(KOD)$ 宣布，其新型抗体生物聚合物结合物Tarcocimab tedromer（KSI-301；tarcocimab）的BEACON 3期研究达到了主要终点，即与阿夫利贝特相比，视网膜静脉闭塞导致的黄斑水肿患者在第24周的视力变化不低于基线。Tarcocimab还显示出强大的解剖学反...查看全文
牛唐2022-06-02 11:21
医药板块速评（2022.06.01）
本期内容提示：
1、9月暂停加息预期打破，大盘后续走势如何看？
2、多家公司市值低于现金，哪些烟蒂股有反转机会？
3、$Kodiak Sciences(KOD)$ 积极股东介入，是否有反转机会？
$特斯拉(TSLA)$ $哔哩哔哩(BILI)$查看全文
牛唐2022-02-24 22:45
医药板块速评（2022.02.23）
本期内容提示：
1、大盘暴跌，如何搭建做空工具组合？
2、大跌之下，哪些医药股有抄底机会？
3、$Kodiak Sciences(KOD)$ 暴跌，知名机构重仓，是否有抄底机会？
$百济神州-U(SH688235)$ $药明康德(SH603259)$查看全文
PracticeOnly2022-02-24 10:27
$Kodiak Sciences(KOD)$ ，其实只说明了一点，生物医药不确定性太大了，不是每个人都能承受得起动辄20%甚至50%以上的跌幅。如果真想好了从中淘金，最好分散点。当然，异常自信的除外。不要自信心爆棚，但投资结果又很糟糕，那就不是“自信”是“自负”了。查看全文
$Kodiak Sciences(KOD)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-22-062523 Act: 34 Size: 106 KB 网页链接
$Kodiak Sciences(KOD)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001564590-22-019301 Act: 33 Size: 172 KB 网页链接
$Kodiak Sciences(KOD)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-22-008988 Act: 34 Size: 294 KB 网页链接
$Kodiak Sciences(KOD)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-22-008956 Act: 34 Size: 5 MB 网页链接
$Kodiak Sciences(KOD)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-22-127573 Act: 34 Size: 364 KB 网页链接
$Kodiak Sciences(KOD)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-22-127534 Act: 34 Size: 2 MB 网页链接
$Kodiak Sciences(KOD)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000080255-22-002302 Act: 34 Size: 6 KB 网页链接
$Kodiak Sciences(KOD)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902219-22-000024 Act: 34 Size: 33 KB 网页链接
$Kodiak Sciences(KOD)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000834237-22-008930 Act: 34 Size: 12 KB 网页链接
$Kodiak Sciences(KOD)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-22-002555 Act: 34 Size: 13 MB 网页链接